has been studied.
Norepinephrine and dopamine concentrations in brain were 30 per cent higher and brain catecholamine formation was 50
per cent higher in the nicotinic acid-supplemented rats than the nicotinic acid-deficient rats. However, these catecholamine levels of the nicotinic acid-deficient rats were recovered by the administration of nicotinic acid .
The concentration of brain tyrosine was unaltered after administration of nicotinic acid to the nicotinic acid-deficient rats . Therefore, the changes catecholamine formation by the nicotinic acid supplementation were not due to the difference of tyrosine concentration in the brain which is the precursor for catecholamine biosynthesis.
As the difference of catechol amine concentration between the nicotinic acid deficient and the nicotinic acid supplemented group was smaller than that of catecholamine forma tion of these groups, the turnover of catecholamine was supposed to be decreased in nicotinic acid deficiency.
Nicotinic acid has been recognized as the responsible factor for pellagra , which was frequently observed with disturbances of the central nervous system , leading to dementia (1, 2) . In addition, the administration of antagonistic agents of nicotinic acid caused mental deficiency (3) .
Catecholamines such as norepinephrine and dopamine are hormones of the nervous system, and existed in brain exclusively within the neurons, where they probably function as neurotransmitters (4, 5) . Both are synthesised from tyro sine (6, 7) , and the synthesis in vivo is controlled by the initial enzyme in the biosynthetic pathway, tyrosine hydroxylase (8) .
The important known role of nicotinic acid is a formation of pyridine nu cleotides. In the brain, almost all the nicotinic acid is present as pyridine nu cleotides (9, 10) . SINGAL et al. demonstrated that nicotinic acid in the brain was markedly decreased in the nicotinic acid-deficient rat (11) . Tyrosine hydroxylase was demonstrated to require the catalytic activity of a tetrahydropteridine co factor and can be coupled with NADH oxidation by dihydropteridine reduc tase (8, 12, 13) . Therefore, nicotinic acid seemed to affect the activity of tyrosine hydroxylase and metabolism of catecholamines in the brain and nervous systems.
The experiments described in this report show that nicotinic acid deficiency results in a deficit of both brain norepinephrine and dopamine contents, and also decreased the synthesis of brain norepinephrine. (27) .
MATERIALS AND METHODS
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Effect of nicotinic acid on growth of rats fed a nicotinic acid deficient diet The growth response curves of weanling rats fed the nicotinic acid-deficient diet or the nicotinic acid-supplemented diet (10mg per 100g diet) are shown in Fig. 1 . The body weight gain of animals fed the nicotinic acid-deficient diet was much less than that of the group given the nicotinic acid-supplemented diet. Body weight of the rats fed the nicotinic acid-deficient diet for 20 days, however, was increased by the administration of the nicotinic acid-supplemented diet. In the nicotinic acid-supplemented animals, calculated values for the formation of dopa, dopamine and norepinephrine were 2 times greater than those in nicotinic acid-deficient rats.
UDENFRIEND and ZALTZMAN-NIERENBERG demonstrated that the specific activities of noradrenaline and dopamine fractions reached a maximal value within 2 hours following administration of 14C-labeled tyrosine by intraperitoneal injection to guinea pig, and fell extremely rapidly over a period of 16 to 24 hours (6). The half-life of brain dopamine was about 2.5 hours. The half-life of norepine phrine was about 4 hours, suggesting a very rapid turnover rate of these catechol amines. SHOEMAKER and WURTMAN demonstrated that early nutritional depriva tion results in a deficit in brain norepinephrine (28, 29) . The data described in this paper, showed that both brain dopamine and norepinephrine contents are about 30 per cent, and the rate of formation of catecholamine is about 50 per cent lower in the nicotinic acid-deficient rat than the nicotinic acid-supplemented rat. The difference in the catecholamine content between these two groups was smaller than the difference of catecholamine formation. From these data, it was there fore considered that the turnover of brain catecholamine was decreased in the nicotinic acid-deficient rat. Further, it was supposed that brain catecholamine was conserved by the decrease of the rate of catecholamine degradation when nicotinic acid supply limits their synthesis in the nicotinic acid-deficient rat.
The amount of 14C-tyrosine in brain of the nicotinic acid-deficient rat was greater than that in the nicotinic acid-supplemented rats (Table 4) . In order to clarify the causes, we investigated the time course of the amount of isotope appear ing in the expired CO2, serum and brain after the administration of 14C-tyrosine. In the nicotinic acid-deficient rats, the amount of isotope appearing in the expired CO2 in each time was smaller than the nicotinic acid-supplemented rats. On the other hand, the disappearance of 14C-tyrosine in serum was rapid after administra tion of nicotinic acid to the nicotinic acid-deficient rats. It was clarified from these results that the turnover of 14C-tyrosine in the body was smaller than that of the nicotinic acid-deficient rats, was supposed to be due to results of the rapid disappearance of 14C-tyrosine in serum.
Although nicotinic acid deficiency resulted in an increase of uptake of 14C -tyrosine into the brain, tyrosine concentrations in brain of the nicotinic acid deficient and the nicotinic acid-supplemented rats remained unaltered. There fore, the increase of catecholamine formation by the administration of nicotinic acid was not due to the changes of the concentration of tyrosine, the precursor for catecholamine biosynthesis.
The following observations were considered to be the reasons that the cate cholamine formations in brain of the nicotinic acid-deficient rat was decreased than that of the nicotinic acid-supplemented rat: 1) The activity of tyrosine hydro xylase, the rate-limiting enzyme in catecholamine biosynthesis, is decreased in the nicotinic acid-deficient rat (8) , and 2) the concentration of tetrahydropteridine cofactor, which coupled with NADH oxidation by dihydropteridine reductase, is decreased in nicotinic acid deficiency (18, 26, 27) .
Further studies are necessary to clarify the role of nicotinic acid in the forma tion of catecholamine in vivo.
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